Search Results - "Paredes Ruiz, Diana"
-
1
Methylprednisolone Pulses and Prolonged Remission in Systemic Lupus Erythematosus: A Propensity Score Analysis of the Longitudinal Lupus‐Cruces‐Bordeaux Inception Cohort
Published in Arthritis care & research (2010) (01-08-2024)“…Objective The objective of this study was to analyze the effect of methylprednisolone pulses (MP), given during the first year after the diagnosis of systemic…”
Get full text
Journal Article -
2
Multidisciplinary management in chronic myeloid leukemia improves cardiovascular risk measured by SCORE
Published in Frontiers in pharmacology (19-07-2023)“…Cardiovascular events are one of the main long-term complications in patients with chronic myeloid leukemia (CML) receiving treatment with tyrosine kinase…”
Get full text
Journal Article -
3
Ustekinumab for corticodependent immune-mediated colitis by pembrolizumab, an alternative for patients with concomitant liver injury
Published in Revista española de enfermedades digestivas (01-06-2022)“…Pembrolizumab, a programmed cell death receptor (PD-1) inhibitor, have improved the prognosis in several types of cancer. Despite the important clinical…”
Get full text
Journal Article -
4
P65 Cluster-based propensity score analysis of glucocorticoid usage and lupus remission: a pilot study
Published in Lupus science & medicine (14-03-2024)“…ObjectiveThis study aimed to determine the impact of glucocorticoid (GC) usage patterns within the first year of diagnosis on achieving prolonged remission in…”
Get full text
Journal Article -
5
Clinical Characteristics and Risk Factors for Mortality in Very Old Patients Hospitalized With COVID-19 in Spain
Published in The journals of gerontology. Series A, Biological sciences and medical sciences (01-03-2021)“…Abstract Background Advanced age is a well-known risk factor for poor prognosis in COVID-19. However, few studies have specifically focused on very old…”
Get full text
Journal Article -
6
Systemic lupus erythematosus and glucocorticoids: A never-ending story?
Published in Best practice & research. Clinical rheumatology (01-12-2023)“…Glucocorticoids (GCs) continue to be essential agents for the management of systemic lupus erythematosus, since there are no other drugs able to active…”
Get full text
Journal Article -
7
Thrombotic antiphospholipid syndrome: From guidelines to clinical management
Published in Medicina clinica (01-08-2024)“…Thrombotic manifestations, mainly venous thromboembolism (VTE) and stroke, are the most common and potentially life-threatening presentations of…”
Get more information
Journal Article -
8
Use of Glucocorticoids in SLE: A Clinical Approach
Published in Mediterranean journal of rheumatology (01-06-2024)“…Glucocorticoids (GCs) are one of the most effective first-line treatments for systemic lupus erythematosus (SLE). However, GC burden is associated with damage…”
Get full text
Journal Article -
9
No Effect of Low-Dose Glucocorticoid Maintenance Therapy on Damage in SLE Patients in Prolonged Remission: A Propensity Score Analysis of the Longitudinal Lupus-Cruces-Bordeaux Inception Cohort
Published in Journal of clinical medicine (11-10-2024)“…: Prolonged remission on low-dose glucocorticoids (GC) is a main goal in patients with systemic lupus erythematosus (SLE). The aim of this study is to assess…”
Get full text
Journal Article -
10
Cytomegalovirus reactivation in patients with immune-mediated gastritis
Published in Enfermedades infecciosas y microbiologia clinica (English ed.) (01-05-2023)“…Reactivation of cytomegalovirus can complicate the evolution of patients with gastritis induced by immune checkpoint inhibitors. The experience in our center…”
Get full text
Journal Article -
11
Clinical Features and Risk Factors for Mortality Among Long-term Care Facility Residents Hospitalized Due to COVID-19 in Spain
Published in The journals of gerontology. Series A, Biological sciences and medical sciences (01-04-2022)“…COVID-19 severely impacted older adults and long-term care facility (LTCF) residents. Our primary aim was to describe differences in clinical and…”
Get full text
Journal Article -
12
Incidence of venous thromboembolism in patients with non-hematological cancer admitted for COVID-19 at a third-level hospital in Madrid
Published in Journal of thrombosis and thrombolysis (01-02-2022)“…An increased risk of venous thromboembolism (VTE) in hospitalized patients with COVID-19 has been reported. We aimed to describe the incidence rate of VTE on…”
Get full text
Journal Article -
13
Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary Thromboembolism
Published in Journal of clinical medicine (12-10-2022)“…(1) Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been reported to increase the risk of pulmonary thromboembolism…”
Get full text
Journal Article -
14
Reactivación de citomegalovirus en pacientes con gastritis inmunomediada
Published in Enfermedades infecciosas y microbiología clínica (01-05-2023)“…La reactivación de citomegalovirus (CMV) puede complicar la evolución de los pacientes con gastritis inducida por los inhibidores de puntos de control…”
Get full text
Journal Article -
15
Reactivación de citomegalovirus en pacientes con gastritis inmunomediada
Published in Enfermedades infecciosas y microbiologia clinica (English ed.) (01-05-2023)Get full text
Journal Article -
16
Ustekinumab for corticodependent immune-mediated colitis by pembrolizumab, an alternative for patients with concomitant liver injury
Published in Revista española de enfermedades digestivas (01-06-2022)“…Keywords: Corticodependent immune-mediated colitis. Cholestatic liver injury. Checkpoint inhibitors…”
Get full text
Journal Article